Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Beneski Benjamin Machinas. Insider active across 2 companies, notably Allogene Therapeutics, Inc.. Cumulatively, 7 filings have been recorded. Split: 0 buy · 6 sells. Total volume traded: €54k. History available since 1 March 2025. The latest transaction was disclosed on 31 March 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Beneski Benjamin Machinas is SVP, Chief Technical Officer at Allogene Therapeutics, Inc. He has 7 filings, and the 7 sampled filings, from 2025-03-05 to 2026-04-02, are all sell transactions for a total of EUR 54237.